[{"id":"bc39ab78-40de-4c87-a343-8cc08b803775","acronym":"PHANTOM","url":"https://clinicaltrials.gov/study/NCT06298916","created_at":"2024-03-07T21:32:59.829Z","updated_at":"2025-02-25T13:56:04.717Z","phase":"Phase 1/2","brief_title":"64Cu-LNTH-1363S in Patients with Sarcoma or Gastrointestinal Tract Cancer","source_id_and_acronym":"NCT06298916 - PHANTOM","lead_sponsor":"Lantheus Medical Imaging","biomarkers":" FAP","pipe":" | ","alterations":" FAP expression","tags":["FAP"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e FAP expression"],"overall_status":"Recruiting","enrollment":" Enrollment 32","initiation":"Initiation: 02/01/2025","start_date":" 02/01/2025","primary_txt":" Primary completion: 11/01/2025","primary_completion_date":" 11/01/2025","study_txt":" Completion: 04/01/2026","study_completion_date":" 04/01/2026","last_update_posted":"2025-02-20"},{"id":"c5069877-91bb-4251-94b9-54a5d23f9ae6","acronym":"LuMIERE","url":"https://clinicaltrials.gov/study/NCT04939610","created_at":"2023-10-21T07:12:22.742Z","updated_at":"2025-02-25T14:40:52.491Z","phase":"Phase 1/2","brief_title":"A Study of 177Lu-FAP-2286 in Advanced Solid Tumors","source_id_and_acronym":"NCT04939610 - LuMIERE","lead_sponsor":"Novartis Pharmaceuticals","biomarkers":" FAP","pipe":" | ","alterations":" FAP expression","tags":["FAP"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e FAP expression"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e lutetium Lu 177 rofapitide tetraxetan (AAA614)"],"overall_status":"Recruiting","enrollment":" Enrollment 222","initiation":"Initiation: 07/30/2021","start_date":" 07/30/2021","primary_txt":" Primary completion: 06/30/2026","primary_completion_date":" 06/30/2026","study_txt":" Completion: 06/30/2028","study_completion_date":" 06/30/2028","last_update_posted":"2025-02-14"},{"id":"7b3bac70-3f26-4678-853d-4e103fc87546","acronym":"FAPI-46 PDAC","url":"https://clinicaltrials.gov/study/NCT05262855","created_at":"2023-10-21T07:12:23.972Z","updated_at":"2024-07-02T16:35:06.288Z","phase":"Phase 2","brief_title":"Study of [68Ga]FAPI-46 PET in Patients With Pancreatic Ductal Carcinoma","source_id_and_acronym":"NCT05262855 - FAPI-46 PDAC","lead_sponsor":"SOFIE","biomarkers":" FAP","pipe":" | ","alterations":" FAP expression","tags":["FAP"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e FAP expression"],"overall_status":"Recruiting","enrollment":" Enrollment 60","initiation":"Initiation: 05/02/2022","start_date":" 05/02/2022","primary_txt":" Primary completion: 12/31/2024","primary_completion_date":" 12/31/2024","study_txt":" Completion: 12/31/2024","study_completion_date":" 12/31/2024","last_update_posted":"2024-05-02"},{"id":"b8b2ac8e-5390-408d-8aee-1199bda614d5","acronym":"FAPI-PET","url":"https://clinicaltrials.gov/study/NCT05160051","created_at":"2021-12-16T13:53:32.405Z","updated_at":"2024-07-02T16:35:09.860Z","phase":"Phase 2","brief_title":"68Ga-FAPI-46 PET for Imaging of FAP Expressing Cancer","source_id_and_acronym":"NCT05160051 - FAPI-PET","lead_sponsor":"University Hospital, Essen","biomarkers":" FAP","pipe":" | ","alterations":" FAP expression","tags":["FAP"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e FAP expression"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e [177Lu]FAPI-46"],"overall_status":"Completed","enrollment":" Enrollment 158","initiation":"Initiation: 12/01/2021","start_date":" 12/01/2021","primary_txt":" Primary completion: 03/06/2024","primary_completion_date":" 03/06/2024","study_txt":" Completion: 03/06/2024","study_completion_date":" 03/06/2024","last_update_posted":"2024-04-12"},{"id":"fcb310b1-7109-4950-b9ce-a0716eaa4d58","acronym":"FoCus","url":"https://clinicaltrials.gov/study/NCT06191120","created_at":"2024-01-04T16:18:07.968Z","updated_at":"2024-07-02T16:35:23.000Z","phase":"","brief_title":"FAPI Molecular Imaging for Diagnosis of the CMS4 Unfavorable Colorectal Cancer Subtype","source_id_and_acronym":"NCT06191120 - FoCus","lead_sponsor":"UMC Utrecht","biomarkers":" CXCL8 • ACTA2 • FAP • COL1A1 • MMP1 • RSPO3 • CXCL1 • CXCL14 • MMP3 • BMP4","pipe":" | ","alterations":" FAP expression","tags":["CXCL8 • ACTA2 • FAP • COL1A1 • MMP1 • RSPO3 • CXCL1 • CXCL14 • MMP3 • BMP4"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e FAP expression"],"overall_status":"Not yet recruiting","enrollment":" Enrollment 45","initiation":"Initiation: 04/01/2024","start_date":" 04/01/2024","primary_txt":" Primary completion: 04/01/2026","primary_completion_date":" 04/01/2026","study_txt":" Completion: 07/01/2031","study_completion_date":" 07/01/2031","last_update_posted":"2024-01-18"},{"id":"4f49ada5-7163-4113-ae94-da85edfc848f","acronym":"","url":"https://clinicaltrials.gov/study/NCT06126705","created_at":"2023-11-13T19:15:39.097Z","updated_at":"2024-07-02T16:35:29.646Z","phase":"Phase 1","brief_title":"18F-AlF-FAPi-04 PET/CT Imaging in Patients With Solid Tumor","source_id_and_acronym":"NCT06126705","lead_sponsor":"Affiliated Hospital of North Sichuan Medical College","biomarkers":" FAP","pipe":" | ","alterations":" FAP expression","tags":["FAP"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e FAP expression"],"overall_status":"Recruiting","enrollment":" Enrollment 60","initiation":"Initiation: 07/18/2023","start_date":" 07/18/2023","primary_txt":"","primary_completion_date":"","study_txt":"","study_completion_date":"","last_update_posted":"2023-11-10"},{"id":"4d093704-3e23-4ea7-aa73-70a41e2fd711","acronym":"","url":"https://clinicaltrials.gov/study/NCT04457258","created_at":"2021-01-18T21:26:08.578Z","updated_at":"2024-07-02T16:35:31.563Z","phase":"Phase 1","brief_title":"68Ga-FAPi-46 PET/CT Scan in Imaging Patients With Sarcoma","source_id_and_acronym":"NCT04457258","lead_sponsor":"Jonsson Comprehensive Cancer Center","biomarkers":" FAP","pipe":" | ","alterations":" FAP expression","tags":["FAP"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e FAP expression"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e [177Lu]FAPI-46"],"overall_status":"Recruiting","enrollment":" Enrollment 30","initiation":"Initiation: 09/08/2020","start_date":" 09/08/2020","primary_txt":" Primary completion: 07/01/2024","primary_completion_date":" 07/01/2024","study_txt":" Completion: 07/21/2025","study_completion_date":" 07/21/2025","last_update_posted":"2023-10-26"},{"id":"839c6292-ffb0-4fbe-890d-7eca80c4a75d","acronym":"FAPI PET Prost","url":"https://clinicaltrials.gov/study/NCT04457232","created_at":"2021-01-18T21:26:07.845Z","updated_at":"2024-07-02T16:35:33.587Z","phase":"Phase 1","brief_title":"Prospective Exploratory Study of FAPi PET/CT in Prostate Cancer With Histopathology Validation","source_id_and_acronym":"NCT04457232 - FAPI PET Prost","lead_sponsor":"Jonsson Comprehensive Cancer Center","biomarkers":" FAP","pipe":" | ","alterations":" FAP expression","tags":["FAP"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e FAP expression"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e [177Lu]FAPI-46"],"overall_status":"Active, not recruiting","enrollment":" Enrollment 30","initiation":"Initiation: 09/09/2020","start_date":" 09/09/2020","primary_txt":" Primary completion: 09/09/2024","primary_completion_date":" 09/09/2024","study_txt":" Completion: 09/09/2025","study_completion_date":" 09/09/2025","last_update_posted":"2023-10-13"},{"id":"aa8467ad-c072-4b95-8f7a-4e50666ebdc6","acronym":"FAPI PET RDRC","url":"https://clinicaltrials.gov/study/NCT04459273","created_at":"2023-10-21T07:12:20.148Z","updated_at":"2024-07-02T16:35:33.555Z","phase":"Phase 1","brief_title":"Prospective Exploratory Study of FAPi PET/CT With Histopathology Validation in Patients With Various Cancers","source_id_and_acronym":"NCT04459273 - FAPI PET RDRC","lead_sponsor":"Jonsson Comprehensive Cancer Center","biomarkers":" FAP","pipe":" | ","alterations":" FAP expression","tags":["FAP"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e FAP expression"],"overall_status":"Recruiting","enrollment":" Enrollment 30","initiation":"Initiation: 08/27/2020","start_date":" 08/27/2020","primary_txt":" Primary completion: 07/01/2024","primary_completion_date":" 07/01/2024","study_txt":" Completion: 07/01/2025","study_completion_date":" 07/01/2025","last_update_posted":"2023-10-13"},{"id":"eccc1076-5c03-4e70-8d73-752bb09c9ffa","acronym":"","url":"https://clinicaltrials.gov/study/NCT05856409","created_at":"2023-10-21T07:12:27.753Z","updated_at":"2024-07-02T16:35:39.812Z","phase":"","brief_title":"Clinical Application of 68Ga-FAPI PET Imaging in Detection of Ovarian Cancer Recurrence","source_id_and_acronym":"NCT05856409","lead_sponsor":"RenJi Hospital","biomarkers":" FAP","pipe":" | ","alterations":" FAP expression","tags":["FAP"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e FAP expression"],"overall_status":"Recruiting","enrollment":" Enrollment 20","initiation":"Initiation: 05/10/2023","start_date":" 05/10/2023","primary_txt":" Primary completion: 04/01/2024","primary_completion_date":" 04/01/2024","study_txt":" Completion: 12/31/2025","study_completion_date":" 12/31/2025","last_update_posted":"2023-08-16"},{"id":"1602156d-4007-4411-b291-f46ae0c69c25","acronym":"PANSCAN-1","url":"https://clinicaltrials.gov/study/NCT05957250","created_at":"2023-10-21T07:12:28.157Z","updated_at":"2024-07-02T16:35:42.138Z","phase":"","brief_title":"[68Ga]Ga-FAPI-46 Positron Emission Tomography (PET) Scan to Improve the Imaging of Pancreatic and Bile Duct Cancer","source_id_and_acronym":"NCT05957250 - PANSCAN-1","lead_sponsor":"Amsterdam UMC, location VUmc","biomarkers":" FAP","pipe":" | ","alterations":" FAP expression","tags":["FAP"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e FAP expression"],"overall_status":"Recruiting","enrollment":" Enrollment 63","initiation":"Initiation: 02/03/2023","start_date":" 02/03/2023","primary_txt":" Primary completion: 07/01/2026","primary_completion_date":" 07/01/2026","study_txt":" Completion: 07/01/2026","study_completion_date":" 07/01/2026","last_update_posted":"2023-07-24"},{"id":"f719892a-b6f5-46fc-9c70-17d240b579a5","acronym":"","url":"https://clinicaltrials.gov/study/NCT04778345","created_at":"2021-03-03T14:56:45.112Z","updated_at":"2024-07-02T16:36:33.862Z","phase":"","brief_title":"Preoperative Abdominal Enhanced CT, 18F-FDG PET/CT and 68Ga-FAPI PET/CT in Peritoneal Carcinomatosis of Gastric Cancer","source_id_and_acronym":"NCT04778345","lead_sponsor":"Fujian Medical University","biomarkers":" FAP","pipe":" | ","alterations":" FAP expression","tags":["FAP"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e FAP expression"],"overall_status":"Not yet recruiting","enrollment":" Enrollment 72","initiation":"Initiation: 03/01/2021","start_date":" 03/01/2021","primary_txt":" Primary completion: 03/01/2022","primary_completion_date":" 03/01/2022","study_txt":" Completion: 03/01/2023","study_completion_date":" 03/01/2023","last_update_posted":"2021-03-03"},{"id":"85862186-4d7e-480a-b17c-fdebf9d139f7","acronym":"","url":"https://clinicaltrials.gov/study/NCT03932565","created_at":"2021-01-18T19:22:13.474Z","updated_at":"2024-07-02T16:36:38.551Z","phase":"Phase 1","brief_title":"Interventional Therapy Sequential With the Fourth-generation CAR-T Targeting Nectin4/FAP for Malignant Solid Tumors","source_id_and_acronym":"NCT03932565","lead_sponsor":"The Sixth Affiliated Hospital of Wenzhou Medical University","biomarkers":" NECTIN4 • CCL19 • FAP","pipe":" | ","alterations":" NECTIN4 expression • FAP expression","tags":["NECTIN4 • CCL19 • FAP"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e NECTIN4 expression • FAP expression"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e CAR-T Targeting Nectin4/FAP"],"overall_status":"Recruiting","enrollment":" Enrollment 30","initiation":"Initiation: 02/13/2019","start_date":" 02/13/2019","primary_txt":" Primary completion: 06/30/2021","primary_completion_date":" 06/30/2021","study_txt":" Completion: 12/31/2021","study_completion_date":" 12/31/2021","last_update_posted":"2020-11-18"},{"id":"ff3f2e67-cd18-4c1d-8576-19a17a15974f","acronym":"","url":"https://clinicaltrials.gov/study/NCT02558140","created_at":"2023-10-21T07:12:17.830Z","updated_at":"2024-07-02T16:37:11.848Z","phase":"Phase 1","brief_title":"A Dose Escalation Study of RO6874813 in Participants With Locally Advanced or Metastatic Solid Tumors","source_id_and_acronym":"NCT02558140","lead_sponsor":"Hoffmann-La Roche","biomarkers":" FAP","pipe":" | ","alterations":" FAP expression","tags":["FAP"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e FAP expression"],"overall_status":"Completed","enrollment":" Enrollment 120","initiation":"Initiation: 10/11/2015","start_date":" 10/11/2015","primary_txt":" Primary completion: 11/06/2017","primary_completion_date":" 11/06/2017","study_txt":" Completion: 11/06/2017","study_completion_date":" 11/06/2017","last_update_posted":"2018-04-04"}]